Digoxin raises mortality risk in A-fib patients, study finds

11/29/2012 | HealthDay News

Atrial fibrillation patients who took digoxin had a 41% higher risk of death from all causes than those who didn't take the drug, according to a study of more than 4,000 patients. In addition, digoxin users were 35% more likely to die from cardiovascular causes and 61% more likely to die from arrhythmias than non-users. The findings were published online in the European Heart Journal.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC